REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. Our NAV Technology Platform, a proprietary AAV gene delivery platform, consists of...
Summary of Position:
This position is for a key team member focused on the development and characterization of high-producing mammalian cell lines for the production of monoclonal antibodies, recombinant proteins and novel molecules. He/she will be...